CryoCath Technologies (Montreal, Quebec), a developer of cryotherapy products to treat cardiovascular disease, reached an agreement with Endocare (Irvine, California) to acquire the exclusive and permanent global rights to SurgiFrost, a surgical probe system to ablate cardiac arrhythmias.
Browse by Speciality Area